Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case–control study

Study limitation reported by the research below: “No specific SGLT2 inhibitor agents are named; findings apply to the class as used in routine Scandinavian clinical practice and may not generalize to all healthcare settings or ethnicities.”